Toll-like receptors in urothelial cells—targets for cancer immunotherapy

Single-nucleotide Polymorphisms in Genes Encoding Toll-like Receptor -2, -3, -4, and -9 in a Case–Control Study with Bladder Cancer Susceptibility in a North Indian Population

(2012) Vibha Singh et al.   ARCHIVES OF MEDICAL RESEARCH

Roles of toll-like receptors in Cancer: A double-edged sword for defense and offense

(2012) Shaherin Basith et al.   ARCHIVES OF PHARMACAL RESEARCH

The application of Toll like receptors for cancer therapy

(2012) Eui Young So et al.   International Journal of Biological Sciences

Toll-like Receptor 4 Gene Polymorphisms and Susceptibility to Bladder Cancer

(2012) Yizhen Shen et al.   PATHOLOGY & ONCOLOGY RESEARCH

Targeting pattern recognition receptors in cancer immunotherapy

(2012) Nadège Goutagny et al.   Targeted Oncology

HP-NAP inhibits the growth of bladder cancer in mice by activating a cytotoxic Th1 response

(2011) Gaia Codolo et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Lung cancer and Toll-like receptors

(2011) Aldo Pinto et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

A delicate dance: host response to mycobacteria

(2011) Kassidy K Huynh et al.   CURRENT OPINION IN IMMUNOLOGY

Maximizing Cure for Muscle-Invasive Bladder Cancer: Integration of Surgery and Chemotherapy

(2011) Andrew H. Feifer et al.   EUROPEAN UROLOGY

Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review

(2011) Sven van den Bosch et al.   EUROPEAN UROLOGY

EAU Guidelines on Non–Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 Update

(2011) Marko Babjuk et al.   EUROPEAN UROLOGY

179 A PRECLINICAL PLACEBO CONTROLLED EFFICACY STUDY WITH R-837 AND TMX-202 IN AN ORTHOTOPIC RAT BLADDER CANCER MODEL

(2011) J. Falke et al.   EUROPEAN UROLOGY SUPPLEMENTS

Association of polymorphisms in TLR genes and in genes of the Toll-like receptor signaling pathway with cancer risk

(2011) Anton G. Kutikhin   HUMAN IMMUNOLOGY

Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and Immunity

(2011) Taro Kawai et al.   IMMUNITY

Toll-Like Receptors in Normal and Malignant Human Bladders

(2011) Cherifa Ayari et al.   JOURNAL OF UROLOGY

A Review of Current Guidelines and Best Practice Recommendations for the Management of Nonmuscle Invasive Bladder Cancer by the International Bladder Cancer Group

(2011) Maurizio Brausi et al.   JOURNAL OF UROLOGY

Toll-Like Receptor Responses of Normal Human Urothelial Cells to Bacterial Flagellin and Lipopolysaccharide

(2011) Nicholas J. Smith et al.   JOURNAL OF UROLOGY

Adjuvant engineering for cancer immunotherapy: Development of a synthetic TLR2 ligand with increased cell adhesion

(2010) Takashi Akazawa et al.   CANCER SCIENCE

Intravesical Toll-like receptor 7 agonist R-837: Optimization of its formulation in an orthotopic mouse model of bladder cancer

(2010) Tomoko Hayashi et al.   INTERNATIONAL JOURNAL OF UROLOGY

Mycobacterium tuberculosis and TLR2 Agonists Inhibit Induction of Type I IFN and Class I MHC Antigen Cross Processing by TLR9

(2010) D. P. Simmons et al.   JOURNAL OF IMMUNOLOGY

Enhanced Tumor Eradication by Combining CTLA-4 or PD-1 Blockade With CpG Therapy

(2010) Sara M. Mangsbo et al.   JOURNAL OF IMMUNOTHERAPY

The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

(2010) Taro Kawai et al.   NATURE IMMUNOLOGY

Targeting Toll-like receptors: emerging therapeutics?

(2010) Elizabeth J. Hennessy et al.   NATURE REVIEWS DRUG DISCOVERY

Toll-like receptor expression in normal ovary and ovarian tumors

(2009) Mingfu Zhou et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Toll-like receptor signaling in cell proliferation and survival

(2009) Xinyan Li et al.   CYTOKINE

An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guérin for Non–Muscle-Invasive Bladder Cancer

(2009) Per-Uno Malmström et al.   EUROPEAN UROLOGY

Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy

(2009) Bas W.G. van Rhijn et al.   EUROPEAN UROLOGY

Bacillus Calmette–Guerin immunotherapy for urothelial carcinoma of the bladder

(2009) Timothy P Kresowik et al.   Immunotherapy

CpG Therapy is Superior to BCG in an Orthotopic Bladder Cancer Model and Generates CD4+ T-cell Immunity

(2009) Sara M. Mangsbo et al.   JOURNAL OF IMMUNOTHERAPY

Morphological study on Mycobacterium bovis BCG Tokyo 172 cell wall skeleton (SMP-105)

(2009) Yuko Uenishi et al.   JOURNAL OF MICROBIOLOGICAL METHODS

Intravesical Mycobacterial Cell Wall-DNA Complex in the Treatment of Carcinoma In Situ of the Bladder After Standard Intravesical Therapy Has Failed

(2009) Alvaro Morales et al.   JOURNAL OF UROLOGY

Toll-Like Receptor Polymorphisms and Susceptibility to Urinary Tract Infections in Adult Women

(2009) Thomas R. Hawn et al.   PLoS One

Genetic Variation of the Human Urinary Tract Innate Immune Response and Asymptomatic Bacteriuria in Women

(2009) Thomas R. Hawn et al.   PLoS One

Cancer Statistics, 2008

(2008) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

TLR4 Signaling Induces B7-H1 Expression Through MAPK Pathways in Bladder Cancer Cells

(2008) Yigang Qian et al.   CANCER INVESTIGATION

Activation of Toll-like receptor 2 by a novel preparation of cell wall skeleton from Mycobacterium bovis BCG Tokyo (SMP-105) sufficiently enhances immune responses against tumors

(2008) Masashi Murata   CANCER SCIENCE

TLR-mediated immune responses in the urinary tract

(2008) Jeongmin Song et al.   CURRENT OPINION IN MICROBIOLOGY

Innate and adaptive immune responses in the urinary tract

(2008) J. Song et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Evolution of intravesical immunotherapy for bladder cancer: mycobacterial cell wall preparation as a promising agent

(2008) Alvaro Morales   EXPERT OPINION ON INVESTIGATIONAL DRUGS

TLR2 – promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity

(2008) Ulrich Zähringer et al.   IMMUNOBIOLOGY

Regulation of TLR4-induced IL-6 response in bladder cancer cells by opposing actions of MAPK and PI3K signaling

(2008) Yigang Qian et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Cancers take their Toll—the function and regulation of Toll-like receptors in cancer cells

(2008) R Chen et al.   ONCOGENE

TLR signaling by tumor and immune cells: a double-edged sword

(2008) B Huang et al.   ONCOGENE

Role of neutrophils in BCG immunotherapy for bladder cancer

(2008) Mark P. Simons et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Mycobacterium bovis BCG Toll-Like Receptors 2 and 4 Cooperation Increases the Innate Epithelial Immune Response

(2007) Patricia Méndez-Samperio et al.   ARCHIVES OF MEDICAL RESEARCH